What has prevented the expansion of insulin sensitisers?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.15, Iss.3, 2006-03, pp. : 205-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin-sensitisers in the treatment of polycystic ovary syndrome

By Teede Helena J Meyer C Norman RJ

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2419-2427

Informa Healthcare

Access to resources Recommend Favorite

Insulin sensitisers and prompt revascularisation offer little cost benefit

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 592, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Diabetes: the latest developments in inhibitors, insulin sensitisers, new drug targets and novel approaches

By Rondinone Cristina M

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 415-418

Informa Healthcare

Access to resources Recommend Favorite

Salix Pharmaceuticals has announced that rifaximin has effectively prevented the development of hepatic encephalopathy

Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

What has gone wrong with modern medical care?

By Turner-Warwick Margaret

Clinical Medicine, Vol. 4, Iss. 4, 2004-07 ,pp. : 343-344

Royal College Of Physicians

Access to resources Recommend Favorite